|
Treatment
Options > Who
Should Be Treated > AASLD Practice Guidelines
Who Should Be Treated
AASLD Practice Guidelines
Two of the nation's leading liver specialists, Anna Lok, M.D.,
and Brian McMahon, M.D., developed practice guidelines for chronic
hepatitis B that were first approved by the American Association
for the Study of Liver Diseases (AASLD) in 2001, and published in
Hepatology, a medical journal for liver diseases (December 2001).
In light of new advances in the field, these guidelines were updated
in the fall of 2003 and published again in Hepatology (March 2004).
Drs. Lok and McMahon provide an excellent review of the current
state of knowledge in hepatitis B. Their conclusion answers the
important treatment questions as to who should be treated and with
what therapies.
For more information, read our Summary
of AASLD 2004 Updated Guidelines for Chronic HBV. Click
here to read the  complete
report .
|
HBF Drug Watch
With promising new compounds in development
for hepatitis B, there is great hope that a cure will be found in the near
future. Visit the HBF Drug
Watch for a complete list of approved hepatitis
B drugs and compounds in development, as well as our list of Hepatitis
B Clinical Trials.
Download Our Information Sheet:
Hepatitis
B Treatment
|
